Healthcare Industry News: Insulet
News Release - April 22, 2014
Cellnovo Strengthens Senior Management Team with Three Key HiresCreates Cellnovo France
SWANSEA, Wales, April 22, 2014 -- (Healthcare Sales & Marketing Network) --Cellnovo, the leading innovator in Mobile Diabetes Management and insulin patch pump technologies, announces the appointments of three experienced executives to the senior management team. Bart Bergstein has been appointed as Chief Financial Officer, Steve Bubrick as Vice President Global Marketing and Business Development, and Didier Moire as Area Director of newly created Cellnovo France.
Bart Bergstein has a 24 year track record in the financial industry including 14 years in Venture Capital. After joining the private equity arm of ABN AMRO in 1997, Bart established the AMRO Life Sciences Team that later spun out as Forbion Capital Partners.
Steve Bubrick has more than 20 years of experience in the diabetes industry. He joins Cellnovo from Asante Solutions where he held the position of Vice President Commercial Operations. Prior to Asante, Steve held senior commercial positions at Insulet, Abbott, Therasense and Lifescan where he was involved in bringing disruptive monitoring and insulin delivery products to markets worldwide. Steve will also be in charge of laying the foundations of Cellnovo's business in North America, starting with overseeing its regulatory filing process.
Recognising the importance of the diabetes market in France, Cellnovo has created a subsidiary in the country with an office in Paris, where Didier Moire will be based and responsible for sales in France, Belgium and Luxembourg. Didier has more than 25 years' experience in Medical Technology and Diagnostics. He was previously Managing Director France/Benelux for Immucor and also held senior positions in Chiron and Novartis.
Eric A. Beard, Executive Chairman of Cellnovo, said: "I am absolutely delighted to welcome Bart, Steve and Didier to the Cellnovo senior management team. All three are experienced executives and entrepreneurs who will be major contributors to the success of the Company and the launch of our novel insulin delivery and diabetes management technologies."
Cellnovo, a UK-based medical device company, is a leading innovator in Mobile Diabetes Management technology. The Company's proprietary Diabetes Management System comprises a wireless connected patch pump, mobile touchscreen handset/controller with an integrated blood glucose meter and applications. This system provides intuitive operation, wireless Internet connectivity and real-time tracking, all industry firsts which represent a revolution for insulin pump technology. For further information, please visit http://www.cellnovo.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.